(c)  

	Number of patients	Grade			Grade
		0-1	≥2	P =	0–2	≥3	P =
Age
≤65 years	72	62 (86.1%)	10 (13.9%)	0.730	69 (95.8%)	3 (4.2%)	0.497
>65 years	51	45 (88.2%)	6 (11.8%)		50 (98.0%)	1 (2.0%)
Dose
64.8 Gy	18	17 (94.4%)	1 (5.6%)	0.278	18 (100.0%)	0 (0.0%)	0.527
70.2 Gy	105	90 (85.7%)	15 (14.3%)		101 (96.2%)	4 (3.8%)
ENI
No	52	48 (92.3%)	4 (7.7%)	0.071	50 (96.2%)	2 (3.8%)	0.566
Yes	71	59 (83.1%)	12 (16.9%)		69 (97.2%)	2 (2.8%)
AHT
No	38	35 (92.1%)	3 (7.9%)	0.050	37 (97.4%)	1 (2.6%)	0.264
Bicalutamide	48	44 (91.7%)	4 (8.3%)		45 (93.8%)	3 (6.3%)
LH-RH agonist	37	28 (75.7%)	9 (24.3%)		37 (100.0%)	0 (0.0%)

ENI: elective nodal irradiation; AHT: adjuvant hormonal therapy.